---
title: "Nymox Pharmaceutical Corporation (NYMXF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NYMXF.US.md"
symbol: "NYMXF.US"
name: "Nymox Pharmaceutical Corporation"
industry: "生物技術"
---

# Nymox Pharmaceutical Corporation (NYMXF.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 美股市場 |
| Website | [nymox.com](https://nymox.com) |

## Company Profile

Nymox Pharmaceutical Corp.（尼莫克斯制藥公司）是一家生物制藥公司，致力于為老年人口研發產品。其產品包括 NicAlert 和 TobacAlert，以及用于治療低級別局部前列腺癌的 NX-1207。公司在加拿大、美國和歐洲等地區開展業務。該公司由保羅·艾弗巴克（Paul Averback）于1995年5月30日創立，總部位于巴哈馬拿騷地區。

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.91 | 181/604 | - | - | - |
| PB | -0.60 | 477/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/NYMXF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NYMXF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NYMXF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.